CalciMedica (CALC) Earnings Date & Reports

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CALC is expected to report earnings to rise 35.29% to -46 cents per share on May 10

Q1'23

Est.

$-0.46

Q4'22

Beat

by $0.08

Q3'22

Missed

by $0.05

Q2'22

Beat

by $0.02

Q1'22

Missed

by $0.10

The last earnings report on March 20 showed earnings per share of -34 cents, beating the estimate of -41 cents. With 38.34K shares outstanding, the current market capitalization sits at 24.54M.

View a ticker or compare two or three

Compare

CALC